End-to-end therapeutics

Enhancing therapeutics to meet clinical need

With the University of Nottingham’s new Biodiscovery Institute at its heart, End-to-end therapeutics draws together core strengths in discovery science arising from small molecules, proteins and materials. Our research then translates these discoveries to pre-clinical and early stage clinic applications and development of therapeutics and devices.